HRES 803

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Bill status

Status
In committee
Sponsor
Rep. John W. Rose [R-TN-6]
Cosponsors
11
Policy area
Health
Introduced
2025-10-10
Latest action
2025-10-10: Referred to the House Committee on Energy and Commerce.

Committee referrals

Recent actions

  • 2025-10-10: Referred to the House Committee on Energy and Commerce.
  • 2025-10-10: Submitted in House
  • 2025-10-10: Submitted in House